ArticleMediterranean journal of rheumatology2023

Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation.

Theodoros DimitroulasPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.